These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10191975)

  • 1. Current therapies for secondary prevention after myocardial infarction.
    Cannon CE; Smith SC
    Curr Opin Cardiol; 1999 Mar; 14(2):155-60. PubMed ID: 10191975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.
    Vittinghoff E; Shlipak MG; Varosy PD; Furberg CD; Ireland CC; Khan SS; Blumenthal R; Barrett-Connor E; Hulley S;
    Ann Intern Med; 2003 Jan; 138(2):81-9. PubMed ID: 12529088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic therapies after myocardial infarction.
    Rapaport E; Gheorghiade M
    Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention in acute myocardial infarction.
    Mehta RH; Eagle KA
    BMJ; 1998 Mar; 316(7134):838-42. PubMed ID: 9549457
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary prevention following myocardial infarction: a clinical update.
    Isted A; Williams R; Oakeshott P
    Br J Gen Pract; 2018 Mar; 68(668):151-152. PubMed ID: 29472228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of patients with ischemic heart disease and diabetes].
    Zaliūnas R; Babarskiene MR; Brazdzionyte J
    Medicina (Kaunas); 2004; 40(2):192-7. PubMed ID: 15007279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment after myocardial infarction].
    Beurrier D; Danchin N
    Presse Med; 1994 Feb; 23(8):380-4. PubMed ID: 7911570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction.
    Gutstein DE; Fuster V
    Clin Cardiol; 1998 Mar; 21(3):161-8. PubMed ID: 9541759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Risk factors and treatment in women with coronary artery disease.
    Ann Intern Med; 2003 Jan; 138(2):I10. PubMed ID: 12529114
    [No Abstract]   [Full Text] [Related]  

  • 12. Which drugs benefit diabetic patients for secondary prevention of myocardial infarction? DARTS/MEMO Collaboration.
    MacDonald TM; Butler R; Newton RW; Morris AD
    Diabet Med; 1998 Apr; 15(4):282-9. PubMed ID: 9585392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors.
    Kaski JC; Fernandez-Berges D
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):185-91. PubMed ID: 18317916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlipid primary and secondary prevention strategies for coronary heart disease.
    Maron DJ
    Clin Cardiol; 1996 May; 19(5):419-23. PubMed ID: 8723603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prevention of acute coronary syndromes: are we following correctly the guidelines?].
    Casella G; Greco C; Maggioni AP; Di Pasquale G
    G Ital Cardiol (Rome); 2006 Mar; 7(3):176-85. PubMed ID: 16572983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reperfusion for acute myocardial infarction: is the future in plastics?
    Rao SV; Jollis JG
    Mayo Clin Proc; 2000 Oct; 75(10):991-3. PubMed ID: 11040845
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secondary prevention of cardiovascular diseases].
    Schneider CA; Erdmann E
    Internist (Berl); 2004 Jun; 45 Suppl 1():S23-30. PubMed ID: 15148584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.